Showing results (761-770 of 826) with videos related to

Sort By:
Pageof 83
Hematological Oncology|July 21, 2019
Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD NetworkIrene Della Starza, Marzia Cavalli, Lucia Anna De Novi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2011
Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myelomaAnnunziata De Luisi, Arianna Ferrucci, Addolorata M L Coluccia, et al.
Leukemia & Lymphoma|January 7, 2016
Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient programPier Luigi Zinzani, Cinzia Pellegrini, Giuseppe Cerciello, et al.
Blood|November 15, 2011
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemiaDavide Rossi, Silvia Rasi, Giulia Fabbri, et al.
Blood|September 21, 2011
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaRobin Foà, Antonella Vitale, Marco Vignetti, et al.
Oncotarget|February 18, 2016
Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genesMonica Messina, Sabina Chiaretti, Jiguang Wang, et al.
The Oncologist|May 6, 2020
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease BurdenFilippo Pietrantonio, Fotios Loupakis, Giovanni Randon, et al.
Leukemia Research|February 1, 2015
"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese"G Mele, A Melpignano, G Quarta, et al.
Blood|August 18, 2022
Endothelial cell-leukemia interactions remodel drug responses, uncovering T-ALL vulnerabilitiesLuca Vincenzo Cappelli, Danilo Fiore, Jude M Phillip, et al.
Cell Death Discovery|March 3, 2026
SPINK2 silencing suppresses leukemic proliferation and restores myeloid commitment via MECOM downregulation in acute myeloid leukaemiaAntonio Benedetto Ventura, Tiziana Loconte, Amer Ahmed, et al.
Pageof 83